A detailed history of Embree Financial Group transactions in Pfizer Inc stock. As of the latest transaction made, Embree Financial Group holds 18,187 shares of PFE stock, worth $451,037. This represents 0.09% of its overall portfolio holdings.

Number of Shares
18,187
Previous 18,079 0.6%
Holding current value
$451,037
Previous $506 Million 4.05%
% of portfolio
0.09%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$27.7 - $31.39 $2,991 - $3,390
108 Added 0.6%
18,187 $526 Million
Q2 2024

Aug 01, 2024

SELL
$25.26 - $29.6 $172,045 - $201,605
-6,811 Reduced 27.36%
18,079 $506 Million
Q1 2024

May 03, 2024

SELL
$25.89 - $29.73 $169,268 - $194,374
-6,538 Reduced 20.8%
24,890 $691 Million
Q4 2023

Apr 30, 2024

BUY
$26.13 - $33.94 $821,213 - $1.07 Million
31,428 New
31,428 $905 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Embree Financial Group Portfolio

Follow Embree Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Embree Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Embree Financial Group with notifications on news.